This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Angioplasty Remove Biomarkers Remove Peripheral Arterial Disease
article thumbnail

Abstract 4136687: VTRNA2-1 Promoter Methylation as a Prognostic Biomarker in Peripheral Artery Disease: Implications for Maternal Nutritional Influence

Circulation

NOVEMBER 11, 2024

Inclusion criteria included adults over 20 years old, consent to participate, and a requirement for angioplasty. These findings suggest that VTRNA2-1 promoter methylation status could serve as a valuable biomarker for predicting prognosis and guiding treatment strategies in PAD. 6.97, p=0.024), amputations (HR 2.58, 95% CI 1.02-6.57,

Peripheral Arterial Disease 40
Peripheral Arterial Disease Biomarkers Angioplasty Atherosclerosis 40
article thumbnail

Rise of the Lysenkoist Cardiologists

Dr. Anish Koka

MAY 16, 2023

years of age, P <0.001), cerebral or peripheral artery disease (6.2% MINOCA now encompasses Spontaneous Coronary Artery Dissection (SCAD), a rare condition that is known to manifest primarily in women and affects the epicardial coronary artery. for epicardial coronary disease, and 1.1 - 11.1

Chest Pain 52
Chest Pain Coronary Artery Disease Cancer Heart Attack 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join thousands of Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024